Look for:

Our offer for

GLAXOSMITHKLINE ORD GBP0.25


ISIN:
GB0009252882
WKN:
0925288
2021/03/05 08:03:39
Price
14.282 EUR
Difference -1.29% (-0.19)

General attributes

ISINGB0009252882
SymbolGSK
ExchangeHamburg
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)72,067 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)-
Ask (Ask size)-
Open14.282 EUR
High14.282 EUR
Low14.282 EUR
Close (prev. day)14.468 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures44
Related Options-

PDF Downloads

Annual report: GLAXOSMITHKLINE ORD GBP0.25PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/03/05 08:03:39
Price
14.282 EUR
Difference -1.29% (-0.19)

General attributes

ISINGB0009252882
SymbolGSK
ExchangeHamburg
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)72,067 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)-
Ask (Ask size)-
Open14.282 EUR
High14.282 EUR
Low14.282 EUR
Close (prev. day)14.468 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6M1Y3Y
Perf (%)-12.02%-26.90%-3.45%
Perf (abs.)-1.95-5.26-0.51
Beta0.830.650.69
Volatility22.8430.1923.03
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)14.257 EUR (331)
Ø price 30 days | Ø volume 30 days (pcs.)14.816 EUR (851)
Ø price 100 days | Ø volume 100 days (pcs.)15.324 EUR (928)
Ø price 250 days | Ø volume 250 days (pcs.)16.741 EUR (540)
YTD High | date16.146 EUR (2021/01/27)
YTD Low | date14.002 EUR (2021/03/02)
52 Weeks High | date20.000 EUR (2020/04/20)
52 Weeks Low | date14.002 EUR (2021/03/02)

All listings for GLAXOSMITHKLINE ORD GBP0.25

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/03/0517:3514.59 EUR3.27351
Tradegate2021/03/0522:2614.608 EUR1.11216
Stuttgart2021/03/0518:5114.60 EUR0.2225
SIX Swiss Exchange2020/04/2117:3621.50 CHF0.001
Munich2021/03/0512:1714.32 EUR0.003
London Stock Exchange2021/03/0517:381,244.80 GBp12,129.9719,693
Hanover2021/03/0518:1414.636 EUR0.012
Hamburg2021/03/0508:0314.282 EUR0.001
Frankfurt2021/03/0517:5714.578 EUR0.2112
FINRA other OTC Issues2021/03/0515:3717.00 USD0.0113
Duesseldorf2021/03/0519:3114.548 EUR0.0020
Berlin2021/03/0512:2114.33 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2549&ID_TYPE_IMAGE_LOGO=2

Contact Details

GLAXOSMITHKLINE PLC
- -
980 Great West Road - TW8 9GS Middlesex
Telefon: 44-20-8047-5000
Fax: 44-20-8047-7807
E-mail: -

PDF Downloads

Annual report: GLAXOSMITHKLINE ORD GBP0.25PDF Download

Company Profile

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Members of Management Board

Emma WalmsleyChairman of Managing Board
Jon EllisMember of Executive Committee
Lon CardonMember of Executive Committee
Neil BarnesMember of Executive Committee
Rab PrinjhaMember of Executive Committee
Brian McNamaraMember of Executive Committee
David RedfernMember of Executive Committee
Deborah WaterhouseMember of Executive Committee
Diana ConradMember of Executive Committee
James FordMember of Executive Committee
Karenann TerrellMember of Executive Committee
Kevin SinMember of Executive Committee
Luke MielsMember of Executive Committee
Marc JonesMember of Executive Committee
María Cristina Henriquez de LunaMember of Executive Committee
Maya Martinez-DavisMember of Executive Committee
Nick HironsMember of Executive Committee
Philip ThomsonMember of Executive Committee
Regis Jean-Pierre SimardMember of Executive Committee
Roger ConnorMember of Executive Committee

Board of directors

Jonathan SymondsChairman of Supervisory Board
Hal BarronMember of Supervisory Board
Jesse GoodmanMember of Supervisory Board
Laurie GlimcherMember of Supervisory Board
Charles BancroftMember of Supervisory Board
Iain MackayMember of Supervisory Board
Judy LewentMember of Supervisory Board
Lynn ElsenhansMember of Supervisory Board
Manvinder Singh BangaMember of Supervisory Board
Urs RohnerMember of Supervisory Board
Vivienne CoxMember of Supervisory Board





Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.